When you have a bleeding disorder, staying on top of treatment regimens can prevent devastating consequences. Adherence is associated with...

Jordan Shavit, MD, PhD, pays forward the support he’s received from NHF.

After decades of research, gene therapy for hemophilia is here—but questions remain.

From academia to industry to advocacy, the National Hemophilia Foundation’s new president and CEO, Leonard Valentino, MD, has done it...

Telemedicine can bridge the distance between doctor and patients.

Last September, scientists, doctors, advocates and people with hemophilia gathered in Washington, DC, for the National Hemophilia Foundation’s (NHF) 15th...

In May 2018, more than 200 people representing scientific researchers, hemophilia patients, advocates, clinicians and the pharmaceutical industry gathered in...

Welcoming a new NHF-Shire clinical fellow.

NHF-Shire Clinical Fellowship Program award recipients are committed to bleeding disorders clinical care and research.

Advances in bleeding disorders care rely on research, but is taking part in a study right for you?

Assessing the My Life, Our Future Genotyping Project A recent article in the journal Haemophilia analyzed the My Life, Our...

On February 23 and 24, an international group of researchers from universities, industry and government gathered in Washington, DC, for...